Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HES
Hess
HES
|
+$1.28B |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$1.02B |
| 3 |
Bank of America
BAC
|
+$770M |
| 4 |
Gilead Sciences
GILD
|
+$378M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$346M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.78B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$973M |
| 3 |
Walt Disney
DIS
|
+$588M |
| 4 |
Eli Lilly
LLY
|
+$569M |
| 5 |
AT&T
T
|
+$529M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.4% |
| 2 | Healthcare | 3.08% |
| 3 | Financials | 2.41% |
| 4 | Consumer Discretionary | 2.33% |
| 5 | Industrials | 1.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11401
TScan Therapeutics
TCRX
$52.8M
| $90.8K | ﹤0.01% |
+11,432
| New | +$71.9K |
|
11402
CALL
BlackRock TCP Capital
TCPC
$342M
| $90.7K | ﹤0.01% |
8,700
-17,400
| -67% | -$192K |
|
11403
PUT
Xtrackers Harvest CSI 500 China A-Shares Small Cap ETF
ASHS
$34.9M
| $90.7K | ﹤0.01% |
+3,500
| New | +$90K |
|
11404
Nutriband Inc Warrant
NTRBW
| $90.6K | ﹤0.01% |
113,189
+88,070
| +351% | +$29.2K |
|
|
PROF
11405
Profound Medical
PROF
$241M
| $90.5K | ﹤0.01% |
10,607
-9,111
| -46% | -$76K |
|
11406
PUT
iShares MSCI Switzerland ETF
EWL
$2.21B
| $90.4K | ﹤0.01% |
1,900
+500
| +36% | +$23.7K |
|
11407
CALL
Riskified
RSKD
$875M
| $90.3K | ﹤0.01% |
16,700
+7,400
| +80% | +$35.2K |
|
11408
CALL
SiriusPoint
SPNT
$2.76B
| $90.2K | ﹤0.01% |
7,100
-4,400
| -38% | -$52.4K |
|
11409
Sight Sciences
SGHT
$448M
| $90.2K | ﹤0.01% |
+17,082
| New | +$80.3K |
|
11410
PUT
CareTrust REIT
CTRE
$9.16B
| $90.2K | ﹤0.01% |
3,700
-10,100
| -73% | -$228K |
|
11411
PUT
PCB Bancorp
PCB
$399M
| $89.8K | ﹤0.01% |
+5,500
| New | +$91.3K |
|
11412
SHF Holdings
SHFS
$2.11M
| $89.8K | ﹤0.01% |
4,653
+1,034
| +29% | +$21.6K |
|
11413
CALL
Towne Bank
TOWN
$3.5B
| $89.8K | ﹤0.01% |
3,200
-1,500
| -32% | -$41.7K |
|
|
NAGE
11414
CALL
Niagen Bioscience
NAGE
$239M
| $89.8K | ﹤0.01% |
25,800
+23,000
| +821% | +$42.6K |
|
|
SLRN
11415
CALL
DELISTED
ACELYRIN
SLRN
| $89.8K | ﹤0.01% |
13,300
-79,000
| -86% | -$600K |
|
|
RNTX
11416
Rein Therapeutics
RNTX
$69.5M
| $89.8K | ﹤0.01% |
+13,810
| New | +$66.1K |
|
11417
Locafy Ltd Warrant
LCFYW
| $89.6K | ﹤0.01% |
30,276
+2,120
| +8% | +$7.49K |
|
11418
CALL
Simplify Interest Rate Hedge ETF
PFIX
$179M
| $89.6K | ﹤0.01% |
2,000
-13,300
| -87% | -$614K |
|
11419
CALL
1st Source
SRCE
$2.13B
| $89.1K | ﹤0.01% |
+1,700
| New | +$87.1K |
|
11420
CALL
Victory Capital Holdings
VCTR
$7.27B
| $89.1K | ﹤0.01% |
2,100
-9,800
| -82% | -$361K |
|
11421
CALL
Precigen
PGEN
$2.18B
| $89K | ﹤0.01% |
61,400
+47,400
| +339% | +$68.1K |
|
11422
PUT
Brady Corp
BRC
$4.44B
| $88.9K | ﹤0.01% |
1,500
-1,000
| -40% | -$59.7K |
|
11423
CALL
ClearSign Technologies
CLIR
$31.7M
| $88.9K | ﹤0.01% |
9,210
+8,850
| +2,458% | +$94.2K |
|
11424
CALL
Workhorse Group
WKHS
$33.3M
| $88.9K | ﹤0.01% |
126
-10
| -7% | -$8.63K |
|
11425
Liquidia Corp
LQDA
$6.66B
| $88.6K | ﹤0.01% |
6,010
-23,024
| -79% | -$320K |
|
Similar funds
Citadel Advisors's Q1 2024 Portfolio in Review
As of Q1 2024, Citadel Advisors held 15,912 positions worth $518B, up 3.6% from $500B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors withdrew a net $36B in Q1 2024, closing 1,439 positions and reducing 6,148 holdings. Its most notable exit was iShares National Muni Bond ETF, an estimated $183M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, down from 3.8% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in TD Synnex worth $245M.
- Citadel Advisors's largest Q1 2024 buy was TD Synnex: 2,162,840 shares worth $245M.
- Citadel Advisors added most to Hess in Q1 2024, an estimated $1.28B increase.
- Citadel Advisors's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $1.78B.
- Citadel Advisors fully exited iShares National Muni Bond ETF in Q1 2024, selling an estimated $183M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q1 2024.
- Citadel Advisors opened 1,749 new positions and closed 1,439 in Q1 2024.
- Citadel Advisors's portfolio value rose 3.6% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q1 2024, filed 15 May 2024.